Armen Garo H bought 16,634 shares of Protagenic Therapeutics, Inc. new at $0.59 for $9.81k on Aug 20, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
EXEC. CHAIR & PRINCIPAL OFF
EXEC. CHAIR & PRINCIPAL OFF
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$9,810.73Shares × reported price
Shares traded
16,634COMMON STOCK
Price per share
$0.59Reported price. Read footnotes for ranges.
% of reported position traded
45.08%This security and ownership context
Holdings after
53,533Direct
Trade date
Aug 20, 2026Buy
Filed
Aug 20, 2026, 8:20 PM ET1-day reporting delay
Accession
0001493152-26-039537Code P · Transaction 15498
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 36,899 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PTIX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTIX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d 0%30d 0%90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.